Patient‐reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma

Authors

Institutions

Publication Details

Journal
Cancer
Published
2026-03-11
DOI
https://doi.org/10.1002/cncr.70345
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient‐reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma

J. Salo, ALFRED D. CHRISTIE, Benjamin Movsas, Jennifer A. Dorth et al.
Cancer
Esophageal Cancer Research and Treatment
article

Patient‐reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma

J. Salo, ALFRED D. CHRISTIE, Benjamin Movsas, Jennifer A. Dorth, Yuhchyau Chen, Jennifer Moughan, R. Aljumaily, Harry H. Yoon, Theodore Sunki Hong, Elizabeth Gore, Carryn M. Anderson, Michael G. Haddock, C.E. Lominska, K. Winter, Lisa A. Kachnic, Dayssy A. Diaz, Samantha A. Seaward, Paul E. O’Brien, Howard P. Safran, Naeem Tahir
article en

Abstract

No abstract available for this paper.
CancerVol. 132(6)
American College of Radiology (US), University of Iowa (US), Geisinger Medical Center (US), Mayo Clinic (US), Kaiser Permanente (US), Medical University of South Carolina (US), Medical College of Wisconsin (US), Columbia University Irving Medical Center (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), Rhode Island Hospital (US), Kaiser Permanente Oakland Medical Center (US), Carolinas Medical Center (US), Massachusetts General Hospital (US), The University of Kansas Cancer Center (US), Levine Cancer Institute (US), Dana-Farber Cancer Institute (US), Center for Cancer Research (US), NRG Oncology (US), University of Oklahoma Health Sciences Center (US), The Ohio State University (US), University of Rochester (US), Case Western Reserve University (US)
Zero hunger
Openalex Percentile: Top 27%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.